Covetrus Receivables

Covetrus (CVET) currently reports a receivables of $660M as of June 2022. That compares with $600M in the prior-year period — up 10.1% year over year. Use the charts on this page to explore Covetrus's receivables history and peer comparisons.

Covetrus's receivables increased from $600M to $660M — a 10.1% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Covetrus reported $660M in receivables as of June 2022. That compares with $600M in the prior-year period — up 10.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $660M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Covetrus, and consider following CVET for alerts when major investors trade the stock.

Covetrus is classified in the Healthcare sector. On receivables, it currently shows $660M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVET with unrelated industries.